| AXA IM GLOBAL EMERGING MARKETS EQUITY QI S USD ACC | RVI EMERGENTES | 16,739409 | 09/04/2026 | 10,19% | 74,51% | ***** |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES D USD | RVI EMERGENTES | 208,900300 | 09/04/2026 | 12,54% | 74,51% | ***** |
| MAN JAPAN COREALPHA EQUITY I EUR | RVI JAPÓN | 411,670000 | 09/04/2026 | 9,72% | 74,46% | **** |
| MSIF GLOBAL INSIGHT A (USD) | RVI GLOBAL | 68,968763 | 09/04/2026 | -13,57% | 74,46% | ***** |
| MAN JAPAN COREALPHA EQUITY I SEK | RVI JAPÓN | 28,797867 | 09/04/2026 | 9,78% | 74,44% | **** |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES D EUR | RVI EMERGENTES | 353,500000 | 09/04/2026 | 12,49% | 74,44% | ***** |
| NORDEA 1-EMERGING EX CHINA SUSTAINABLE STARS EQUITY FUND BI-USD | RVI EMERGENTES | 184,014463 | 09/04/2026 | 15,23% | 74,43% | **** |
| NORDEA 1-EMERGING EX CHINA SUSTAINABLE STARS EQUITY FUND BI-EUR | RVI EMERGENTES | 183,975100 | 09/04/2026 | 15,25% | 74,40% | **** |
| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS | BIOTECNOLOGÍA | 62,467692 | 09/04/2026 | 8,69% | 74,40% | **** |
| DAVIS VALUE FUND I DIS USD | RVI USA VALOR | 110,937099 | 09/04/2026 | 4,02% | 74,33% | ***** |
